Home/Adagio Medical/John Blaho, PhD
JB

John Blaho, PhD

President & CEO

Adagio Medical

Therapeutic Areas

Adagio Medical Pipeline

DrugIndicationPhase
Adagio SystemAtrial Fibrillation (Paroxysmal and Persistent)Phase 3